After the treatment with 100 and 200 mg/kg gefitinib, the expression level of Ki-67 in the tumor markedly decreased (Figure 1E and F), whereas there was no significant change in the expression level of EGFR (Figure 1B and C). This evidence concerns the gene MKI67 and neoplasm.